Governor announces nanotechnology hub, $1.5 billion investment in SUNY IT Marcy campus

Governor announces nanotechnology hub in Marcy /Courtesy: Jim Kenyon

MARCY, ONEIDA CO. -- Governor Andrew Cuomo came to the SUNY IT campus in Marcy Thursday to announce the creation of Nano Utica.

The governor announced that six global technology companies intend to invest $1.5 billion to create the state's second major hub of nanotechnology research and development.

The governor says thepublic-private partnership will create more than 1,000 high-tech jobs on the campus of SUNY IT. Among the companies involved are Sematech, Advanced Nanotechnology Solutions Inc. (ANSI), IBM, Lam Research and Tokyo Electron. The governor said, "The new Nano Utica facility will serve as a clean room and research hub for Nano Utica whose members can tap into the training here at SUNY IT and local workforce putting the Mohawk Valley on the map as an international location for nanotechnology research and development."

The computer chip packaging consortium will work inside a complex which is now under construction on the SUNY IT campus due to open in late 2014.

Visit link:

Governor announces nanotechnology hub, $1.5 billion investment in SUNY IT Marcy campus

There Is No Nanotechnology Equivalent to the Digital Divide

A recent article in the venerable Financial Timesproposed a sort of nanotechnology equivalent to theoft-mentioned digital divide(the idea thatthe benefits of digital technology appear to accrue to the wealthy while the poor are left out). At issue in the articleis whether developed economies and poorer nations are separated in their respective access to nanotechnology.

So, is there a nanotech divide?

The answer probably lies somewhere between yes and no, depending on the metric you use. But I would argue that nanotechnology has been one of the most egalitarian fields in technology history.

First, you can look at where the money goes. On this count, nanotechnology is basically the same as any other emerging technology: the initial targeted applications are those that can sustain the price premium for using a new and expensive technology.

However, nanomaterials can already be found in inexpensive items ranging from odor-resistant socks to plastic beer bottles. So as the manufacturing technologies have matured and ramped up, we have seen prices fall and the democratization of nano-enabled products spread.

But I've often argued that analyzing nanotech's impact purely on economic terms can be misleading. It is usually a stretch to try to draw parallels between an emerging technology like nanotech and a developed field like information technology. Nanotech is still in its commercial infancy.

Instead, let's focus just on nanotechnology research, which constitutes the bulk of the activity in the field today. With nanotech, we are probably witnessing the most democratic and open-access research ever in a new technology.

Every day, articles along every conceivable line of nanotech research are publishedand made available on the web, with an increasing number of articles being published with open access to everyone. If there remains a divide here, it stems from a digital dividenot from nanotech itself.

We see this open access play out in the way that most research is now conducted: through international research groups working in cooperation with each other. This has actually been proven through quantitative analysis. Nanotechnology research is international and depends on cross-border cooperation if it is to succeed. Granted, most of this research goes on in developed nations, but not exclusivelyover 35 countries have announced funding for nanotechnology initiatives.

Finally, you can look at who's benefitting from nanotechnoloy. On that front, their are numerous projects that target developing countries, like improved membranes for creating clean drinking waterand systems tosterilize medical equipment in remote regions of the world. In fact, I am hard pressed to think of an emerging technology in which so much of its R&D and its financial backers are so heavily invested in making an impact in the developing world.

View post:

There Is No Nanotechnology Equivalent to the Digital Divide

Increased R&D Interest to Drive the Global Market for Nanotechnology in Drug Delivery, According to a Soon to be …

San Jose, California (PRWEB) October 11, 2013

Follow us on LinkedIn GIA invites senior industry executives, domain experts, technologists and market strategists to participate in a comprehensive global research initiative studying the market for Nanotechnology in Drug Delivery. The study will examine key drivers and trends impacting the market such as technology developments in drug delivery nanosystems; expanding nanotechnology applications in nasal, oral and epidermal drug delivery routes; heavy R&D investments and development of novel nanocarriers; breakthrough developments in the concept of Clever drug targeting systems.

An important sector of the Nanomedicine industry, Nanotechnology in Drug Delivery is defined as the application of nanotechnology in drug delivery. Nano Drug Delivery techniques involve encapsulation of nano size particles of drugs in polymer matrices that have targeting ligands that bind to diseased cells for controlled release of drugs. Key benefits of nano drug delivery systems triggering R&D interests include targeted and accurate intracellular delivery of drugs and reduced immune system response and resulting side effects; sustained and controlled release of drugs for optimum clinical impact and patient outcome; and superior retention of bioactivity of drugs by protecting them from environmental degradation. Promising areas of nanodrug delivery systems which are expected to witness the maximum impact in terms of investor interest and market opportunities include injectable drugs, oral drugs, implantable drug delivery systems, external topical delivery, and transdermal delivery, among others.

The upcoming years are expected to witness nanodrug delivery systems expand to include drug compounds for cancer and infectious diseases. R&D efforts are already underway to develop ethylene glycol molecules based nanoparticles capable of transporting chemotherapy drugs directly to tumour cells. Another key breakthrough in the oncology field is the development of nanosponge drug delivery system capable of significantly reducing tumour growth as compared to conventional injectable drugs. Cardiology also represents a promising area with studies underway to develop nanoparticles to deliver clot busting drugs. In this regard, iron oxide based nanoparticles are being researched for their ability to deliver drugs directly to stents implanted within the arteries.

A key factor fuelling R&D investments in nanodrug delivery systems is the growing pressure on pharmaceutical companies to develop breakthrough novel next generation drugs against a backdrop of intense competition from generics as most second generation drugs continue to lose patents. Also the aging world population is pushing up unmet medical needs among the elderly creating an urgent need for novel and effective therapies. The paradigm shift of the pharma industry towards personalized medicine will additionally lend traction to nanotechnology-enabled drug delivery therapies that target the molecular cause of the disease. Poised to gain in the future are delivery systems that enable individualized pharmacotyping and patient specific delivery of drugs. The study estimates Nanotechnology in Drug Delivery to be a multi-million dollar market worldwide, while more precise market-size and growth projections will be made available during the 2nd stage of report preparation, and data analysis.

The research and analyses will be released shortly in the form of a comprehensive research report. The report by design, will attempt to provide exhaustive analysis, data, trends, market share, market size, statistics, forecasts and competitive intelligence. The report is modeled to offer precise and unbiased, actionable market insights including in-depth segmentation of market sub-sectors, demand estimates and projections and analysis of trends in each of the sectors, identification of leading players, and the competitive structure, among others.

Developed for Drug Developers/Manufacturers, Strategic Planners, Business Development Executives, Management Consultants, Investment Bankers, Consulting Firms, Marketing & Sales Executives, C-Level Decision Makers, Market Strategists and Technology Domain Experts, the report helps identify the biggest opportunities in this space and offers accurate latent demand forecasting that empowers quantitative decision making among existing market players and new entrants.

For more details about how you can participate, please click here.

About Global Industry Analysts, Inc.

Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Read the original:

Increased R&D Interest to Drive the Global Market for Nanotechnology in Drug Delivery, According to a Soon to be ...

Nanotechnology and Learning to Talk to Bacteria: Reginald C. Farrow, Ph.D. at TEDxNJIT – Video


Nanotechnology and Learning to Talk to Bacteria: Reginald C. Farrow, Ph.D. at TEDxNJIT
The most well-known advances in nanotechnology have led to dramatically smaller devices that provide us very fast, compact and "smart" electronics including ...

By: TEDxTalks

Go here to see the original:

Nanotechnology and Learning to Talk to Bacteria: Reginald C. Farrow, Ph.D. at TEDxNJIT - Video

DNA nanotechnology opens new path to super-high-resolution molecular imaging

Public release date: 3-Oct-2013 [ | E-mail | Share ]

Contact: Dan Ferber dan.ferber@wyss.harvard.edu 617-432-1547 Wyss Institute for Biologically Inspired Engineering at Harvard

A team at the Wyss Institute for Biologically Inspired Engineering at Harvard University has been awarded a special $3.5 million grant from the National Institutes of Health (NIH) to develop an inexpensive and easy-to-use new microscopy method to simultaneously spot many tiny components of cells.

The grant, called a Transformative Research Award, is part of an NIH initiative to fund high-risk, high-reward research, and in 2013 the agency funded just 10 of these projects nationally.

The DNA-based microscopy method could potentially lead to new ways of diagnosing disease by distinguishing healthy and diseased cells based on sophisticated molecular details. It could also help scientists uncover how the cell's components carry out their work inside the cell.

"If you want to study physiology and disease, you want to see how the molecules work, and it's important to see them in their native environments," said Peng Yin, Ph.D., a core faculty member at the Wyss Institute and Assistant Professor of Systems Biology at Harvard Medical School. Yin will lead the project, and he will collaborate with Samie Jaffrey, M.D., Ph.D., a Professor of Pharmacology at Weill Cornell Medical College, and Ralf Jungmann, Ph.D., a postdoctoral scholar in Yin's Wyss Institute lab, among others.

Biologists have used microscopes to reveal how tiny structures inside cells prop them up and help them move, reproduce, activate genes, and much more. But although microscope makers have honed the technology for centuries to get ever-clearer images, they have been limited by the laws of physics. When two objects are closer than about 0.2 micrometers, or about one five-hundredth the width of a human hair, the scientists can no longer distinguish them using traditional light microscopes. As a result, the viewer sees one blurry blob where in reality there are two objects. This occurs because of the way light rays bend around objects, and is known as the diffraction limit.

Molecules such as enzymes, receptors, RNA and DNA that do most of the work of the cell are typically far smaller than 0.2 micrometers, and to visualize them, microscopists have struggled to overcome the diffraction limit. They have developed several clever methods that accomplish this, but some of them require special microscopes that tend to be very expensive, and others require cumbersome procedures. What's more, today's methods can only reveal a handful of distinct molecule species at a time, and the images remain blurrier than many scientists would like.

The Wyss Institute-led team plans to overcome these challenges by combining single-molecule imaging methods with molecular tools from DNA nanotechnology. Using an imaging method called DNA-PAINT, they created so-called "imager strands" by tagging small pieces of DNA with a fluorescent dye. Each of these imager strands binds transiently to a matching DNA strand that is attached to a target molecule, which makes the target appear to blink. Such blinking, when done right, enables scientists to beat the diffraction limit and obtain sharper images of the targets than otherwise possible.

"The powerful thing about using DNA lies in its amazing programmability," Yin said. "We plan to use that capability to make molecules in cells blink in a programmable and autonomous way. This will allow us to see things that were previously invisible."

Go here to see the original:

DNA nanotechnology opens new path to super-high-resolution molecular imaging

Nanovations Wins Nanotechnology Supply Contract for Tallest Building in Baku

Sydney Frenchs Forest, NSW, Australia (PRWEB) October 02, 2013

Nanotechnology product manufacturer Nanovations Pty Ltd, announces it has won the contract for the supply of its glass coatings to the Socar Tower project in Baku, Azerbaijan.

The Socar Tower at 209 meters is the highest building in the Caucasus region. The extraordinary skyscraper, in the shape of a burning flame, the signature image of Azerbaijan, comes from the drawing boards of the South Korean architectural firm Heerim Architects and Planners Co Ltd.

Baku is the capital city of the 'Land of Fire', Azerbaijan, and is routinely blasted by strong winds and seismic activity. To resist these challenging conditions, the building can withstand wind speeds of 190 kilometers per hour and is resistant to earthquake measuring 9 on the Richter scale. The tower is build by Turkish Tekfen Construction and Installation Co. Inc.

The highly engineered curtain wall elements of the building are manufactured by Permasteelisa Group, in its new factory complex in Baku. The Permasteelisa Group is the world leader in the design, production and installation of architectural envelopes and curtain walls.

To protect the surface of the outer glass from the elements, and to provide an easy to clean surface, it was decided to coat the glass of the curtain wall panels with the Nanovations NG-1314 coating.

Prior to using the coating, intensive performance testing was conducted at glass laboratories in Europe. The results showed the superior performance of Nanovations products, which lead to Nanovations winning the contract.

In cooperation with Permasteelisa, Nanovations has setup a coating application unit in Baku, with a team of trained and certified applicators that meets the high standards of the Permasteelisa Group.

This partnership has benefited both companies and they believe that the use of the technology in Azerbaijan and beyond, will also have benefits for future projects.

Nanovations durable and effective solutions have been used particularly in buildings and automotive and marine related applications by professional applicators and glass processing firms. The first high rise building, in the world was treated with glass coating solutions from Nanovations.

Read this article:

Nanovations Wins Nanotechnology Supply Contract for Tallest Building in Baku

Paving the Way for Real-world Nanotechnology Products

The multi-party investment will bring together national research organisations, suppliers and manufacturers spanning the nanotechnology value chain, and government agencies to promote the technology. The Foundry is part of a masterplan spearheaded by A*STAR to push translational research and accelerate commercialisation of home-grown technologies. In partnership with other A*STAR research institutes, IMRE will work with companies like Toshiba Machines Co Ltd, EV Group, NTT Advanced Technology Corporation, NIL Technology ApS, Kyodo International Inc., micro resist technology GmbH, Nanoveu Pte Ltd and Solves Innovative Technology Pte Ltd to produce prototypes for real-world products and applications. The Foundry and its partners will also work closely with Singapore's Economic Development Board (EDB) and SPRING to promote its nanoimprint applications to industry as part of the plans to build up Singapore's high-value manufacturing capabilities.

"We can help companies develop up to 20,000 samples for proof-of-concept and pilot production allowing manufacturers to shorten the product cycle but minus the heavy capital R&D investment", said Dr Karen Chong, the IMRE scientist who is heading the Foundry. Dr Chong added that the Foundry will be a one-stop shop for companies seeking to conceive, design and develop solutions for new, revolutionary products based on the versatile nanoimprint technology.

"The Foundry gives us the tools for creating real products that target industry end users and ultimately consumers", explained Mr Masayuki Yagi, Director & General Manager, Advanced Machinery Business Unit, Toshiba Machines Co Ltd, Japan on why the company chose to participate in the initiative. "Toshiba Machines and the Foundry will aim to deliver innovative engineering solutions based on nanoimprint and be the best partner for leading industries.

According to Mr Koh Teng Kwee, Director of Solves Innovative Technology Pte Ltd, "Working with IMRE since ICON 1 , I am sure IMRE's nanoimprint technology and know-how is now ready for industrial adoption. In my opinion, IMRE is able to provide everything needed for a new product realisation involving nanoimprinting."

"There is a billion-dollar, virtually untapped market for new advanced nanotechnology products that can make use of what the Foundry has to offer", said Prof Andy Hor, Executive Director for IMRE, adding that the initiative will hasten the industrialisation of nanoimprinting in this lucrative market segment. In consumer care for example, the global market for contact lenses - where nanoimprint technology can be used to produce new functionalities like multi-coloured lenses - is expected to grow to USD 11.7 billion by 2015 .

"The Foundry is the first one-stop shop to pull different value chain partners together to offer solutions based on nanoimprint through equipment, moulds, materials and applications to end user companies", said Dr Tan Geok Leng, Executive Director of A*STAR's Science and Engineering Research Council which oversees a number of the research institutes dedicated to the physical sciences and engineering. "The new Foundry is part of Singapore's strategy to create a new, advanced high-value manufacturing sector to support its growing knowledge-based economy."

"As part of EDB's vision to position Singapore as an Advanced Manufacturing Hub, we will continue to work with companies to co-create and adopt advanced manufacturing technologies. We see this new Research Foundry as one of the key infrastructures to strengthen nanoscale-manufacturing capabilities in Singapore", said Mr Yi-Hsen Gian, Director (i3), Economic Development Board (EDB), Singapore.

The Foundry was launched on 30 September 2013 during a ceremony that also saw collaboration agreements signed between A*STAR and its industry partners.

1) Industrial Consortium On Nanoimprint, Project 1 on anti-reflection surfaces 2) Global Industry Analysts, Inc.

About A*STAR's Nanoimprint Foundry

Go here to read the rest:

Paving the Way for Real-world Nanotechnology Products

:: 30, Sep 2013 :: PAVING THE WAY FOR REAL-WORLD NANOTECHNOLOGY PRODUCTS

PAVING THE WAY FOR REAL-WORLD NANOTECHNOLOGY PRODUCTS

A*STARs new Nanoimprint Foundry will bridge the gap between laboratory-based nanotechnologies and real-world products. This is the first time that Singapore nanotechnology suppliers and manufacturers have been brought together to speed up productisation of nanoimprinting, a technology that imbues ordinary surfaces with unique properties for applications in sectors like consumer care, biomedical devices, optics, filtration, displays and maritime.

1. Singapore, 30 September 2013 Adhesives that leave no sticky residue, skins that keep medical instruments germ-free, new anti-reflective protectors for displays or surfaces that prevent barnacles from attaching to ships.These are just some of the products that nanoimprinting technology is capable of producing. A*STARs Institute of Materials Research and Engineering (IMRE) and its partners launched a new Nanoimprint Foundry that will develop, test-bed and prototype specially engineered plastics and surfaces for the specific purpose of commercialising the technologies. Possible applications of nanoimprint technology include dry adhesives, aesthetic packaging, contact lenses, biomedical cell scaffolds, anti-frost surfaces and anti-bacteria materials.

2. The multi-party investment will bring together national research organisations, suppliers and manufacturers spanning the nanotechnology value chain, and government agencies to promote the technology. The Foundry is part of a masterplan spearheaded by A*STAR to push translational research and accelerate commercialisation of home-grown technologies. In partnership with other A*STAR research institutes, IMRE will work with companies like Toshiba Machines Co Ltd, EV Group, NTT Advanced Technology Corporation, NIL Technology ApS, Kyodo International Inc., micro resist technology GmbH, Nanoveu Pte Ltd and Solves Innovative Technology Pte Ltd to produce prototypes for real-world products and applications. The Foundry and its partners will also work closely with Singapores Economic Development Board (EDB) and SPRING to promote its nanoimprint applications to industry as part of the plans to build up Singapores high-value manufacturing capabilities.

3. We can help companies develop up to 20,000 samples for proof-of-concept and pilot production allowing manufacturers to shorten the product cycle but minus the heavy capital R&D investment, said Dr Karen Chong, the IMRE scientist who is heading the Foundry. Dr Chong added that the Foundry will be a one-stop shop for companies seeking to conceive, design and develop solutions for new, revolutionary products based on the versatile nanoimprint technology.

4. The Foundry gives us the tools for creating real products that target industry end users and ultimately consumers, explained Mr Masayuki Yagi, Director & General Manager, Advanced Machinery Business Unit, Toshiba Machines Co Ltd, Japan on why the company chose to participate in the initiative. Toshiba Machines and the Foundry will aim to deliver innovative engineering solutions based on nanoimprint and be the best partner for leading industries.

5. According to Mr Koh Teng Kwee, Director of Solves Innovative Technology Pte Ltd, Working with IMRE since ICON 1[1], I am sure IMREs nanoimprint technology and know-how is now ready for industrial adoption. In my opinion, IMRE is able to provide everything needed for a new product realisation involving nanoimprinting.

6. There is a billion-dollar, virtually untapped market for new advanced nanotechnology products that can make use of what the Foundry has to offer, said Prof Andy Hor, Executive Director for IMRE, adding that the initiative will hasten the industrialisation of nanoimprinting in this lucrative market segment. In consumer care for example, the global market for contact lenses - where nanoimprint technology can be used to produce new functionalities like multi-coloured lenses - is expected to grow to USD 11.7 billion by 2015[2].

7. The Foundry is the first one-stop shop to pull different value chain partners together to offer solutions based on nanoimprint through equipment, moulds, materials and applications to end user companies, said Dr Tan Geok Leng, Executive Director of A*STARs Science and Engineering Research Council which oversees a number of the research institutes dedicated to the physical sciences and engineering. The new Foundry is part of Singapores strategy to create a new, advanced high-value manufacturing sector to support its growing knowledge-based economy.

8. As part of EDBs vision to position Singapore as an Advanced Manufacturing Hub, we will continue to work with companies to co-create and adopt advanced manufacturing technologies. We see this new Research Foundry as one of the key infrastructures to strengthen nanoscale-manufacturing capabilities in Singapore, said Mr Yi-Hsen Gian, Director (i3), Economic Development Board (EDB), Singapore.

Read more from the original source:

:: 30, Sep 2013 :: PAVING THE WAY FOR REAL-WORLD NANOTECHNOLOGY PRODUCTS